Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2008
12/04/2008WO2008057579A3 Dosage forms and co-administration of an opioid agonist and an opioid antagonist
12/04/2008WO2008033747A3 Multi-functional small molecules as anti-proliferative agents
12/04/2008WO2007143267A3 Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide
12/04/2008WO2007135505A8 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
12/04/2008US20080300407 Pyridinoylpiperidines as 5-HT1F agonists
12/04/2008US20080300307 Stable gabapentin compositions
12/04/2008US20080300278 central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents; cardiovascular disorders
12/04/2008US20080300276 Heterocyclic Carboxylic Acide Amide Derivatives
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300267 (3-Chloro-phenyl)-[4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-pyrimidin-2-yl]-amine; (4-Fluoro-phenyl)-[4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-pyrimidin-2-yl]-amine; [4-(1H-Pyrrolo[2,3-b]pyridin-4-yl)-pyrimidin-2-yl]-(4-trifluoromethoxy-phenyl)-amine;
12/04/2008US20080300266 metabotropic glutamate receptor (mGluR3) antagonists such as [1-(5-bromopyrimidin-2-yl)-pyrrolidin-3-yl]-(2,4-dichlorobenzyl)-amine, used for the treatment of depression, schizophrenia and headaches
12/04/2008US20080300262 Combination Therapy for Relief of Pain
12/04/2008US20080300260 HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 receptor)
12/04/2008US20080300259 Multimediator 5-Ht6 Receptor Antagonists, and Uses Related Thereto
12/04/2008US20080300257 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES
12/04/2008US20080300256 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics
12/04/2008US20080300253 Treatment of inflammatory disorders with praziquantel
12/04/2008US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300240 Pde10 inhibitors and related compositions and methods
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080300214 Compounds for the Treatment of Marihuana Dependence, Withdrawal, and Usage
12/04/2008US20080300206 Alpha-Synuclein Kinase
12/04/2008US20080300205 Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
12/04/2008US20080300204 Alpha-Synuclein Antibodies and Methods Related Thereto
12/04/2008US20080300178 Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421
12/04/2008US20080300176 Administering granulocyte colony stimulating factors to replenish dopaminergic neuron loss and mobilizes stem cells into peripheral blood of mammal
12/04/2008US20080299596 Substrates and assays for beta-secretase activity
12/04/2008US20080299536 Material and Methods for Nerve Grafting
12/04/2008US20080299231 Herbal composition for treatment of neurodegeneration and neuronal dysfunction
12/04/2008US20080299229 Methods of reducing beta-amyloid polypeptides
12/04/2008US20080299216 Deuterium-enriched aripiprazole
12/04/2008US20080299204 Dosage forms for movement disorder treatment
12/04/2008US20080299189 Controlled release dopamine agonist compositions
12/04/2008US20080299188 Controlled release dosage forms combining immediate release and sustainted release of low-solubility drug
12/04/2008US20080299169 Topographical Templating of Polymeric Materials Using Cellular Morphology
12/04/2008US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof
12/04/2008US20080299135 Methods and compositions for nerve regeneration
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008US20080299125 Genetic basis of treatment response in depression patients
12/04/2008US20080299109 Mechanism of astricyte-neuron signaling
12/04/2008US20080299104 Methods for detecting agents involved in neuronal apoptosis and compositions thereof
12/04/2008US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299050 Topical therapies for oral mucositis and other conditions
12/04/2008US20080299041 Heterocyclic indene derivatives and their radioisotope labeled compounds for imaging beta-amyloid deposition
12/04/2008US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
12/04/2008CA2688327A1 Methods and compositions for stimulating cells
12/04/2008CA2688110A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
12/04/2008CA2688074A1 Pharmaceutical formulation comprising pramipexole
12/04/2008CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
12/04/2008CA2687765A1 Pyrazolopyrrolidines as inhibitors of gamma secretase
12/04/2008CA2687608A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008CA2687321A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008CA2684174A1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease
12/04/2008CA2684172A1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
12/04/2008CA2684171A1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas
12/04/2008CA2683933A1 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/03/2008EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications
12/03/2008EP1997818A2 Quinolinone derivatives and their use to treat pain
12/03/2008EP1997807A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
12/03/2008EP1997806A1 Pahrmaceutical compositions for prevention and treatment of central nervous system disorders
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997501A2 Extracts from Ajuga reptans cell lines, their preparation and use
12/03/2008EP1997500A1 Health tea and method for preparing the same
12/03/2008EP1997496A1 Composition containing riboflavin and sesamins
12/03/2008EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
12/03/2008EP1997493A1 Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
12/03/2008EP1997486A1 Therapeutic agent for functional brain disease
12/03/2008EP1996621A2 Antibodies
12/03/2008EP1996620A1 Affinity regions
12/03/2008EP1996596A2 Substituted imidazo(2,1-b)thiazole compounds and their use for producing drugs
12/03/2008EP1996587A1 Substituted quinazolines as pde10 inhibitors
12/03/2008EP1996584A2 Tropane prodrugs with central nervous system activity
12/03/2008EP1996580A2 Pyrrazole derivatives as sigma receptors antagonists
12/03/2008EP1996574A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/03/2008EP1996562A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
12/03/2008EP1996560A1 Quinazolinones and their use as potassium channels activators
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996554A1 Sigma receptor inhibitors
12/03/2008EP1996548A1 Sigma receptor compounds
12/03/2008EP1996291A2 Use of digitalis-like compounds in the treatment of affective disorders
12/03/2008EP1996227A2 Anti-amyloid immunogenic compositions, methods and uses
12/03/2008EP1996213A2 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1996194A2 Homotropanes with central nervous system activity
12/03/2008EP1996189A1 Benzimidazoles which have activity at m1 receptor and their uses in medicine
12/03/2008EP1996188A1 Benzimidazoles which have activity at m1 receptor and their uses in medicine
12/03/2008EP1996183A1 Method of treatment or prophylaxis inflammatory pain
12/03/2008EP1996177A2 Agents for influencing receptors and consequences thereof
12/03/2008EP1996175A1 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
12/03/2008EP1855677B1 3,11b cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses
12/03/2008EP1682152A4 Compositions and methods for treatment of nervous system disorders
12/03/2008EP1610771B1 Use of an alpha2-adrenoceptor antagonist for the treatment of epilepsy
12/03/2008EP1549615B1 Naphthamide derivatives and their use
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1511499B1 Immunomodulatory compounds and methods of use thereof
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 1833